Pelagos Insurance Capital Limit

$22.94 ▼ -1.46%
2026-06-19 05:16:49

Explore Pelagos Insurance Capital Limit stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$1.96 B
Current Price
$22.94
52W High / Low
$24.06 / $14.8
Stock P/E
6.3
Book Value
$26.36
Dividend Yield
0.03%
ROCE
ROE
0.16%
Face Value
EPS
$3.64
Exp Qtr EPS
Sector
Financial Services

Pros

No pros available.

Cons

No cons available.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. Berkshire Hathaway Inc. $486.38 14.47 $1,049.05 B 0.1% $516.85 / $455.19 $505,559.44
2. Berkshire Hathaway Inc. $728,641 14.45 $1,047.72 B 0.1% $775,000 / $685,150 $505,559.44
3. Sun Life Financial Inc. $79.9 18.96 $43.8 B 0.03% 12.89% $113.56 / $77.38 $32.08
4. American International Group, Inc. $81.06 13.71 $43.33 B 2.48% 7.7% $87.29 / $71.25 $76.44
5. The Hartford Insurance Group, Inc. $139.64 9.45 $38.39 B 1.72% 22.01% $144.5 / $119.61 $68.54
6. Arch Capital Group Ltd. $102.85 7.42 $36.13 B 0% 20.48% $105.09 / $82.45 $67.43
7. Brookfield Wealth Solutions Ltd. $43.81 30.33 $20.82 B 0.42% 2.95% $69 / $55.13 $50.31

Quarterly Results

Figures shown in M / B

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Sales610.5 M274.8 M650.2 M591.3 M655.9 M
Operating Profit117.8 M157.5 M175.9 M31.5 M-41.6 M
Net Profit108 M117.8 M130.5 M19.7 M-42.5 M
EPS in Rs1.161.181.250.18-0.38

Profit & Loss

Figures shown in M / B

2025202420232022
Sales2.17 B2.11 B3.37 B1.52 B
Operating Profit323.3 M170.2 M2.08 B115.6 M
Net Profit225.5 M113.3 M2.13 B52.6 M
EPS in Rs2.120.9818.650.27

Balance Sheet

Figures shown in M / B

2025202420232022
Total Assets12.44 B11.77 B10.03 B8.31 B
Total Liabilities10.04 B9.32 B7.58 B6.33 B
Equity2.4 B2.45 B2.45 B1.98 B
Current Assets
Current Liabilities

Cash Flow

Last available yearly cash flow history

2025202420232022
Operating CF-408.3 M618.2 M495.2 M741.4 M
Investing CF682.7 M-475.8 M-834.9 M215.9 M
Financing CF19.8 M-153.9 M-106.9 M-16.2 M
Free CF-409.5 M613.6 M488.8 M722.6 M
Capex-1.2 M-4.6 M-6.4 M-18.8 M

5Y Margin & Growth History

Last 5 years of annual financial statement data.

2024202320222021
Revenue Growth %-37.31%122.06%
Earnings Growth %-94.69%3954.18%
Profit Margin %5.37%63.34%3.47%
Operating Margin %8.06%61.86%7.62%
Gross Margin %
EBITDA Margin %

Dividend & Split History

Latest dividend payments and stock split events.

Dividend History

Ex DateDividend
2026-06-15$0.15
2026-03-16$0.15
2025-06-16$0.1
2025-03-12$0.1
2024-11-29$0.1
2024-09-16$0.1
2024-06-14$0.1
2024-03-14$0.1

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Holder Name Type Shares Value % Out Report Date
American Century ETF Trust-Avantis U.S. Small Cap Value ETF Mutual Fund 1.09 M $25.07 M 0.01% 2026-05-31
iShares Trust-iShares Russell 2000 ETF Mutual Fund 1.35 M $31.06 M 0.02% 2026-04-30
iShares Trust-iShares Russell 2000 Value ETF Mutual Fund 0.48 M $10.95 M 0.01% 2026-04-30
Crestview Partners III GP, LP Institutional 9.74 M $223.43 M 0.11% 2026-03-31
Cooperman, Leon G. Institutional 7.98 M $183.16 M 0.09% 2026-03-31
Pine Brook Road Advisors, LP Institutional 7.21 M $165.4 M 0.08% 2026-03-31
Travelers Companies, Inc. Institutional 6.63 M $152.16 M 0.08% 2026-03-31
LSV Asset Management Institutional 4.88 M $111.98 M 0.06% 2026-03-31
Crestview Partners IV GP, L.P. Institutional 4.51 M $103.5 M 0.05% 2026-03-31
Blackrock Inc. Institutional 3.3 M $75.71 M 0.04% 2026-03-31
Dimensional Fund Advisors LP Institutional 2.82 M $64.76 M 0.03% 2026-03-31
American Century Companies Inc Institutional 1.31 M $30.12 M 0.02% 2026-03-31
LOOMIS SAYLES & CO L P Institutional 1.26 M $28.87 M 0.01% 2026-03-31
ROYCE FUND-Royce Small-Cap Total Return Fund Mutual Fund 0.73 M $16.75 M 0.01% 2026-03-31
EA Series Trust-EA Bridgeway Omni Small-Cap Value ETF Mutual Fund 0.44 M $10.18 M 0.01% 2026-03-31

Frequently Asked Questions — Pelagos Insurance Capital Limit

Will Pelagos Insurance Capital Limit stock hit $28 in 2026?

Pelagos Insurance Capital Limit (PLGO) is currently trading at $22.94, with a 52-week range of $14.8 to $24.06. Reaching the $28 level would represent a 20% gain from the current price — a target many investors consider when evaluating near-term upside potential.

Wall Street analysts currently have a consensus price target of $23.89 for Pelagos Insurance Capital Limit, with a Hold rating, and the most bullish analysts see the stock reaching as high as $28.0. Whether Pelagos Insurance Capital Limit can reach $28 in 2026 depends on several factors: revenue and earnings growth trajectory, broader market conditions, sector sentiment within the Financial Services space, and any company-specific catalysts such as product launches, earnings beats, or strategic announcements.

Short-term price predictions carry significant uncertainty — stock prices can be influenced by factors ranging from quarterly earnings surprises to global macroeconomic events. Use the PLGO Stock Return Calculator on StockSifting to model different growth scenarios and see how various CAGR assumptions translate to potential price targets. This content is for informational purposes only and does not constitute financial advice.

Is Pelagos Insurance Capital Limit stock worth buying at $22.94?

Whether Pelagos Insurance Capital Limit (PLGO) is worth buying at $22.94 depends on your investment goals, time horizon, and risk tolerance. Here is a breakdown of the key metrics investors typically evaluate:

Valuation: Pelagos Insurance Capital Limit trades at a Price-to-Earnings (P/E) ratio of 6.3x, which can be compared against other Financial Services companies to assess whether the stock is expensive or attractively priced relative to its peers.

Profitability & efficiency: Its Return on Equity (ROE) stands at 0.2%.

Financial health: The Debt-to-Equity ratio of 37.42 indicates a higher degree of financial leverage — investors should monitor debt servicing capacity.

Analyst view: The Wall Street consensus recommendation for PLGO is currently Hold, with a mean price target of $23.89 based on 9 analyst ratings. Always conduct your own due diligence and consider consulting a qualified financial advisor before making any investment decisions. Nothing on StockSifting constitutes financial advice.

What is the analyst price target for Pelagos Insurance Capital Limit (PLGO) in 2026?

As of 2026, Wall Street analysts have set a consensus (mean) price target of $23.89 for Pelagos Insurance Capital Limit (PLGO), aggregated from 9 analyst ratings. The overall analyst recommendation is Hold.

The price target range spans from $20.0 on the bearish end to $28.0 on the most optimistic projection, with a median target of $23.0. This wide range reflects differing views on Pelagos Insurance Capital Limit's growth prospects, competitive positioning, and macroeconomic sensitivity.

It is important to note that analyst price targets are forward-looking estimates based on financial models, earnings projections, and sector assumptions — they are not guarantees. Targets are regularly revised following quarterly earnings results, management guidance updates, or shifts in the broader economic outlook. Stocks can trade significantly above or below analyst targets depending on market conditions. View the full analyst breakdown and track target revisions on the PLGO analysis page on StockSifting.

Is Pelagos Insurance Capital Limit overvalued at a P/E ratio of 6.3x?

Pelagos Insurance Capital Limit (PLGO) currently has a Price-to-Earnings (P/E) ratio of 6.3x, meaning investors are paying $6.3 for every $1 of the company's trailing twelve-month earnings. Whether this makes the stock overvalued depends on several contextual factors:

Sector context: The Financial Services sector tends to command higher valuation multiples when growth expectations are elevated. A 6.3x P/E is relatively low, which could indicate an undervalued opportunity — or it may reflect lower expected growth or higher perceived risk.

Growth-adjusted valuation: A P/E ratio in isolation can be misleading. Fast-growing companies often deserve higher P/E multiples because their future earnings are expected to rise significantly. A more complete picture comes from looking at the PEG ratio (P/E divided by earnings growth rate) — a PEG below 1 is often considered undervalued, while above 2 may signal overvaluation.

Additional metrics to review: P/E is just one lens. Compare it alongside the Price-to-Book (P/B) ratio, EV/EBITDA, Price-to-Sales, and free cash flow yield for a more complete valuation picture. View all of PLGO's valuation ratios on StockSifting's ratios section. Valuation is subjective and context-dependent — this is not investment advice.

What will Pelagos Insurance Capital Limit stock be worth in 2029?

Projecting Pelagos Insurance Capital Limit (PLGO)'s stock price 3 years into the future — to 2029 — requires making assumptions about the company's earnings growth, valuation multiple, and broader market conditions. No projection is guaranteed, but historical growth rates offer a reasonable starting point.

In reality, stock prices rarely follow a straight-line trajectory. Short-term volatility, earnings misses, sector rotations, interest rate changes, and macroeconomic events can all cause significant deviations from any modeled path. Investors with a 3-year horizon should focus on the fundamental business trajectory — revenue growth, expanding margins, and free cash flow generation — rather than short-term price fluctuations.

You can model different scenarios — conservative, base, and bull case — using the PLGO Return Calculator on StockSifting. Enter any investment amount and CAGR assumption to see projected outcomes over your chosen time horizon. All projections are mathematical estimates only and do not constitute financial advice.